- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04284462
Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure
This is a double-blind, controlled, parallel, randomized sensory study. The study will consist of two cohorts; habitual regular full-calorie Carbonated Soft Drink (CSD) consumers and habitual low-calorie CSD consumers. Each cohort will be randomized to one of 3 interventions for six months (24 weeks):
- Intervention 1: Control (full sweetness) beverage
- Intervention 2: Step-wise sweetness reduction series of beverages
- Intervention 3: Moderate sweetness (reduced sweetness) beverage
The primary outcome is to assess the perception changes in sweetness (magnitude scale) and sweetness liking (Likert scale) of a test product and a control product over a period of six months. The study endeavors to explore whether consumers of sweetened carbonated beverages can adapt liking to lower sweetness beverages after prolonged exposure of daily consumption of beverages with step-wise reduction of sweetness, or maintenance at reduced (moderate) sweetness.
The secondary outcome will be to assess dietary compensation for sweetness in the step-wise and moderate reduction arms compared to the control arms (the full calorie and low calorie control beverages). Dietary analysis of calories and intakes of total sugar, added sugar, and servings of low-/non-calorie sweeteners will be assessed using a 3-day diet record pre-intervention and monthly for 6 months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Addison, Illinois, United States, 60101
- Biofortis Innovation Services
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy adults 25-55 years of age
- Habitually consume regular or diet carbonated soft drinks (CSD)
- Willing and able to consume at least one CSD beverage daily for a total of 6 months and abstain from other sweetened beverages
- Willing and able to complete questionnaires regarding dietary intake and sensory perception
- Has internet access via computer, phone or other device and is able to maintain internet access throughout the trial in order to complete daily online questionnaires.
- Participant is judged to be in good health on the basis of medical history and the general health and lifestyle questionnaire.
- Participant is willing to maintain his or her habitual diet, smoking habits and physical activity patterns, including habitual use of study approved medications and/or dietary supplements throughout the study period.
- Participant understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators.
Exclusion Criteria:
- Regular smoker (more than 1 cigarette per week)
- History or presence of clinically important endocrine (including type 1 or 2 diabetes mellitus), cardiovascular, pulmonary, biliary, renal, hepatic, pancreatic, or neurologic disorders that, in the opinion of the Clinical Investigator, could interfere with the interpretation of the study results.
- Extreme dietary habits, including but not limited to vegetarian diets and intentional consumption of a high fiber diet, gluten-free, low-carb, vegan, ketogenic.
- Extreme changes to physical activity
- Females who are pregnant, planning to be pregnant during the study period, lactating, or of childbearing potential and unwilling to commit to the use of a medically approved form of contraception throughout the study period.
- Recent history (within 12 months of screening; Visit 1) of alcohol or substance abuse. Alcohol abuse is defined as >14 drinks per week (1 drink = 12 oz beer, 5 oz wine, or 1½ oz distilled spirits).
- Individual has a condition the Clinical Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, or which might confound the interpretation of the study results or put the participant at undue risk.
- Dislike of study product taste
- Participation in another clinical trial within past 30 days and participation in a PepsiCo clinical trial in the past 6 months.
- People who have phenylketonuria (low calorie sweetened beverages contain aspartame)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
PLACEBO_COMPARATOR: Control beverage for Habitual full-calorie CSD cohort, n=28
Full sweetness (sugar) for 6 months
|
1-2 cans/day (330 ml per can)
|
PLACEBO_COMPARATOR: Control beverage for Habitual low-calorie CSD cohort, n=28
Full sweetness low calorie sweetener (LCS) with sweetness level matched to the full sweetness sugar control for 6 months
|
1-2 cans/day (330 ml per can)
|
ACTIVE_COMPARATOR: Test beverage 1 for Habitual full-calorie CSD cohort, n=28
Reduced sweetness (moderate sugar level) for 6 months
|
1-2 cans/day (330 ml per can)
|
ACTIVE_COMPARATOR: Test beverage 1 for Habitual low-calorie CSD cohort, n=28
Reduced sweetness low calorie sweetener (LCS) with sweetness level matched to the moderate sugar sweetness level for 6 months
|
1-2 cans/day (330 ml per can)
|
ACTIVE_COMPARATOR: Test beverage 2 for Habitual full-calorie CSD cohort, n=28
Step-wise sweetness reduction over 6 months.
Month 1 is the full sweetness sugar control, followed by monthly sweetness reduction.
Remains at the reduced sweetness level (moderate sugar level) from months 4-6.
|
1-2 cans/day (330 ml per can)
|
ACTIVE_COMPARATOR: Test beverage 2 for Habitual low-calorie CSD cohort, n=28
Step-wise sweetness reduction over 6 months.
Month 1 is the low calorie sweetener (LCS) sweetness equivalent of the full sweetness sugar control, followed by monthly LCS sweetness reduction (reductions equivalent to the corresponding sugar reduction arm sweetness levels).
Remains at the reduced sweetness level (LCS equivalent of moderate sugar sweetness level) from months 4-6.
|
1-2 cans/day (330 ml per can)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sweetness liking
Time Frame: Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
|
Likert scale, 9 point scale from 1=Dislike extremely to 9=Like extremely
|
Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
|
Sweetness intensity perception
Time Frame: Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
|
Magnitude scale ranging from Barely perceptible to Strongest imaginable sweetness
|
Changes over a period of 6 months, measured at monthly intervals from month 0 (baseline) to month 6
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dietary compensation for sweetness
Time Frame: Assessed pre-intervention, then monthly x 6 months
|
3-day diet record to assess calories and intake of total sugar, added sugar, low-/non-calorie sweeteners
|
Assessed pre-intervention, then monthly x 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aftertaste
Time Frame: Monthly assessments x 6 months
|
Scale 1-5, 1=Very unpleasant, 5=Very pleasant
|
Monthly assessments x 6 months
|
Aftertaste description
Time Frame: Monthly assessments x 6 months
|
12 description options (ex., sweet, tart, bitter, etc.) or other, check all that apply
|
Monthly assessments x 6 months
|
Likely to buy
Time Frame: One assessment at end of study, month 6
|
Scale from 1-5, 1= Definitely would not buy it, to 5 Definitely would buy it
|
One assessment at end of study, month 6
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathleen Kelley, MD, Biofortis Innovation Services
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PEP-1908
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sweetness Liking Adaptation
-
PepsiCo Global R&DCompletedSweetness Liking AdaptationMexico
-
PepsiCo Global R&DCompletedSweetness Liking AdaptationUnited States
-
Turku University HospitalNovo Nordisk A/S; University of Turku; Academy of Finland; Juho Vainio FoundationCompletedPhysical Exercise Behavior (Liking/Aversion)Finland
-
Centre des Sciences du Goût et de l'AlimentationEuropean Community; Regional Council of BurgundyCompletedConditioning of Caloric Adjustment and Liking in ChildrenFrance
-
Pamukkale UniversityCompletedGynecologic Cancer | Chemotherapy Effect | Mobile Application | Physiological Adaptation | Psychosocial AdaptationTurkey
-
University of ZurichUnknown
-
University of CopenhagenCompleted
-
Hacettepe UniversityCompleted
-
Amsterdam UMC, location VUmcDutch Cancer SocietyRecruitingAdaptation, EmotionalNetherlands
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompleted
Clinical Trials on Flavored carbonated soft drink (CSD)
-
PepsiCo Global R&DCompletedSweetness Liking AdaptationUnited States
-
PepsiCo Global R&DCompletedSweetness Liking AdaptationMexico
-
Abbott NutritionCompletedHospitalized ElderlyUnited States, Puerto Rico
-
University Hospital, Clermont-FerrandUMR 914 PNCA - AgroParisTech, INRA, Université Paris-Saclay; UR370 QuaPA AgroRésonance...Unknown
-
Aarhus University HospitalLG Life SciencesCompletedObesity | Dietary Habits | Metabolic; ComplicationsDenmark
-
University of ZurichUniversity of Lausanne; SNF Swiss National FoundationCompleted
-
Aarhus University HospitalLG Life SciencesCompleted
-
University of TorontoUnity Health Toronto; Cancer Care OntarioCompletedHypertension | Diabetes | Heart DiseaseCanada
-
Coombe Women and Infants University HospitalUnknownPregnancy | Gastric EmptyingIreland
-
German Institute of Human NutritionLudwig-Maximilians - University of MunichCompletedDiabetes | Pre-diabetesGermany